Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for
Aortic Stenosis
Location: Allentown PA, Wynnewood PA, Paramus NJ, New York NY,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18 - 70+
Code: NCT06777368
Recruiting
Active & Responsive
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: Philadelphia PA, Hackensack NJ, Boston MA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04895436
Phase 2, Recruiting
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Allentown PA, West Chester PA, Princeton NJ,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase 2, Recruiting
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
for
Supratentorial Hemorrhage
Location: Edison NJ, Hershey PA, New York NY, Buffalo NY,
Sponsor: Integra LifeSciences Corporation
Sex: All
Age: 18+
Code: NCT04494295
Recruiting
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Location: East Brunswick NJ, New York NY, Baltimore MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218380
Phase 3, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: East Brunswick NJ, Newark DE, Hershey PA, New York NY,